Free Consultation
A free educational consultation with one of our Clinical Educators can be provided for patients who may meet our inclusion criteria. During this phone call, a Patient Intake Specialist will answer any questions that you may have. For any patients facing financial barriers to treatment, the Patient Intake Specialist will also discuss financial options and how we may be able to provide support.
Approximate Therapy & Treatment Cost - $2500 to $6500
*Not determined by or paid to TheraPsil*
If a patient is successfully granted legal access to psilocybin, TheraPsil will ensure this individual is supported by trained and qualified healthcare practitioners who can facilitate their psilocybin-assisted psychotherapy. Like any form of therapy, there is a cost associated with this treatment. TheraPsil does not determine this cost as these TheraPsil Associate Practitioners are often working within their own private practices.
Pricing will vary from practitioner to practitioner and therapy length will vary based on each patient’s needs. As our psilocybin treatment model requires medical oversight from a prescriber as well as two sitters to be present on the treatment day, the cost of the prescriber and co-sitter will be included in the total treatment price.
A total treatment including the preparatory sessions, the treatment day and the integration sessions can take on average around 18 to 25 hours of time. Therapists have service rates of approximately $150 to $200/hr. Although we cannot provide a specific cost estimate, a lower cost for therapy could be $2500 whereas a more lengthy therapy may cost $5000 or more.
Therapists often have sliding scale options for their services for those who can pay more or less. Extended health coverage and/or benefits plans that cover therapy may be utilized to finance treatment.
When connected with a treatment team, patients will be provided specific treatment cost details.
Why These Costs Exist
Providing legal access to psychedelic therapy in Canada—whether with psilocybin or MDMA—requires more than therapy sessions alone. Patients are supported by a network of prescribers, therapists, co-sitters, intake specialists, and administrative staff. In many cases, legal and regulatory navigation is also required to access treatment under the Special Access Program (SAP).
For years, TheraPsil and our partners helped subsidize many of these hidden costs to keep treatment accessible. To continue offering safe and legal support, we now reflect the true cost of what’s involved.
If you're seeking psilocybin therapy through the SAP and want a more detailed explanation of these costs—including why some patients may choose to join a clinical trial instead—click here to read our full explainer.
Subscribe to our newsletter!
Be the first to hear about new trainings, legal updates, and community events. Join TheraPsil’s newsletter and stay connected to Canada’s psychedelic advocacy and training community.
